MAIA Biotechnology Announces Pricing of $30 Million Underwritten Public Offering of Common Stock
Financing included participation by healthcare-dedicated investors alongsideexisting shareholders CHICAGO, IL, March 02, 2026 (GLOBE NEWSWIRE) — MAIA Biotechnology, Inc., (NYSE…
